- Home
- MPV vs FENC Comparison
MPV vs FENC Comparison
Compare MPV & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- FENC
- Stock Information
- Founded
- MPV 1988
- FENC 1996
- Country
- MPV United States
- FENC United States
- Employees
- MPV N/A
- FENC N/A
- Industry
- MPV Finance Companies
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPV Finance
- FENC Health Care
- Exchange
- MPV Nasdaq
- FENC Nasdaq
- Market Cap
- MPV 183.6M
- FENC 181.7M
- IPO Year
- MPV N/A
- FENC 2001
- Fundamental
- Price
- MPV $16.80
- FENC $3.99
- Analyst Decision
- MPV
- FENC Strong Buy
- Analyst Count
- MPV 0
- FENC 2
- Target Price
- MPV N/A
- FENC $14.00
- AVG Volume (30 Days)
- MPV 25.2K
- FENC 116.0K
- Earning Date
- MPV 01-01-0001
- FENC 11-07-2024
- Dividend Yield
- MPV 8.71%
- FENC N/A
- EPS Growth
- MPV N/A
- FENC N/A
- EPS
- MPV 1.71
- FENC N/A
- Revenue
- MPV N/A
- FENC $49,348,000.00
- Revenue This Year
- MPV N/A
- FENC $116.50
- Revenue Next Year
- MPV N/A
- FENC $17.49
- P/E Ratio
- MPV $9.35
- FENC N/A
- Revenue Growth
- MPV N/A
- FENC 278.09
- 52 Week Low
- MPV $11.18
- FENC $3.97
- 52 Week High
- MPV $16.42
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- MPV 49.43
- FENC 38.47
- Support Level
- MPV $16.20
- FENC $3.99
- Resistance Level
- MPV $16.87
- FENC $4.57
- Average True Range (ATR)
- MPV 0.25
- FENC 0.31
- MACD
- MPV -0.06
- FENC -0.02
- Stochastic Oscillator
- MPV 41.10
- FENC 2.33
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.